- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Psychedelics Therapy
Recent news which mentions Psychedelics Therapy
He Tried Ayahuasca! Colombian President Petro Talks About His Psychedelic Experiences Experiences
June 25, 2024
Tickers
NEWS
From Benzinga
The Promise Of Psilocybin When It Comes To Mental Health, And How COMPASS Pathways (NASDAQ: CMPS) Is Advancing It
October 11, 2023
Tickers
CMPS
From Benzinga
Jamaica-Based Kaya Group Partners With Silo Wellness, Announce Share Exchange And Psychedelic Wellness Retreats
August 03, 2023
From Benzinga
NIDA Partners With The National Institute Of Mental Health To Study Psychedelics Potential
May 05, 2023
From Benzinga
From Benzinga
From Benzinga
Studying Psychedelics As Medicine: UK University Offers Postgrad Course On Clinical Use
April 25, 2023
From Benzinga
Psychedelics Producer Lucy Scientific Discovery Partners With Pramantha Group For Funding: What's Next?
March 17, 2023
Tickers
LSDI
From Benzinga
People Science Raises $5.3M For Evolution Of Therapeutic Alternatives: Psychedelics & Cannabis
January 27, 2023
From Benzinga
BREAKING: California's Psychedelics Decrim Bill Back In The Game, Led By State Sen. Scott Wiener
December 19, 2022
From Benzinga
Psychedelics & Environmental Protection: Company Seeks Patents To Synthetically Produce Toad Venom
December 12, 2022
Tickers
PSYBF
From Benzinga
Psychedelic Therapy Boosted By 3D Movement Data? This Company Is Aiming To Patent The Combination
December 07, 2022
Tickers
TRUFF
From Benzinga
LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon
November 21, 2022
From Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
November 16, 2022
Tickers
AGNPF
From Benzinga
Filament Health Shares Q3 2022 Results, On Road To Becoming Industry's Natural Psilocybin Supplier
November 11, 2022
Tickers
FLHLF
From Benzinga
COMPASS Pathways Shares Q3 2022 Financial Results, Business News & Term's Highlights
November 04, 2022
Tickers
CMPS
From Benzinga
New York Update: Will Psychedelics Achieve Legal Status In 2023? Details On A Newly Amended Bill
October 07, 2022
From Benzinga
Can Ketamine Treat Alcohol Addiction? Clinics & Hospitals In Europe And North America Are Already Doing It
September 30, 2022
Tickers
AWKNF
From Benzinga
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
September 23, 2022
Tickers
BMNDF
From Benzinga
Magic Mushrooms Producer Optimi Keeps Betting On The FDA-approval Of Psychedelics
September 01, 2022
Tickers
OPTHF
From Benzinga
First International Psilocybin Supply Agreement For Optimi Health: Here Are The Details
August 30, 2022
Tickers
OPTHF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.